TGFB2 and gastric cancer: Vagenas et al. [25] studied 110 gastric cancer tissues and found that TGF-β2 was highly expressed in late stages and linked to poor prognosis, and upregulated expression of TGF-β2 promoted the progression of gastric tumors.